{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:48:50Z","timestamp":1782082130568,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50043-x","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:25:16Z","timestamp":1777123516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["XGBoost-based model for predicting five-year survival in gastric cancer using clinical indicators"],"prefix":"10.1038","volume":"16","author":[{"given":"Yujiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"2","key":"50043_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. Cancer J. Clin. 66 (2), 115\u2013132. https:\/\/doi.org\/10.3322\/caac.21338 (2016).","journal-title":"Cancer J. Clin."},{"issue":"3","key":"50043_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21657","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi, S. S. & Badgwell, B. D. Current treatment and recent progress in gastric cancer. Cancer J. Clin. 71 (3), 264\u2013279. https:\/\/doi.org\/10.3322\/caac.21657 (2021).","journal-title":"Cancer J. Clin."},{"issue":"1","key":"50043_CR3","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1186\/s12885-021-08872-8","volume":"21","author":"TO G\u00f6tze","year":"2021","unstructured":"G\u00f6tze, T. O. et al. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II\/III adenocarcinoma - the phase III PREVENT- (FLOT9) trial of the AIO \/CAOGI \/ACO. BMC cancer. 21 (1), 1158. https:\/\/doi.org\/10.1186\/s12885-021-08872-8 (2021).","journal-title":"BMC cancer"},{"issue":"7","key":"50043_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s2468-1253(19)30083-4","volume":"4","author":"Y Yamada","year":"2019","unstructured":"Yamada, Y. et al. Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial. lancet Gastroenterol. Hepatol. 4 (7), 501\u2013510. https:\/\/doi.org\/10.1016\/s2468-1253(19)30083-4 (2019).","journal-title":"lancet Gastroenterol. Hepatol."},{"issue":"6","key":"50043_CR5","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1245\/s10434-023-13151-w","volume":"30","author":"AJ Sinnamon","year":"2023","unstructured":"Sinnamon, A. J. et al. Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer. Ann. Surg. Oncol. 30 (6), 3580\u20133589. https:\/\/doi.org\/10.1245\/s10434-023-13151-w (2023).","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"50043_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/s1470-2045(16)30560-5","volume":"18","author":"J Guinney","year":"2017","unstructured":"Guinney, J. et al. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. Lancet Oncol. 18 (1), 132\u2013142. https:\/\/doi.org\/10.1016\/s1470-2045(16)30560-5 (2017).","journal-title":"Lancet Oncol."},{"issue":"20","key":"50043_CR7","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1093\/nar\/gkw677","volume":"44","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data. Nucleic Acids Res. 44 (20), e151. https:\/\/doi.org\/10.1093\/nar\/gkw677 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"50043_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12967-022-03369-9","volume":"20","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer. J. translational Med. 20 (1), 177. https:\/\/doi.org\/10.1186\/s12967-022-03369-9 (2022).","journal-title":"J. translational Med."},{"key":"50043_CR9","doi-asserted-by":"crossref","unstructured":"Kasim, S., Malek, S., Ibrahim, K. & Kumar, D. J. E. H. J. Applying an interpretive machine learning algorithm to predict in-hospital mortality in elderly asian patients with acute coronary syndrome (ACS). ;44(Supplement_1):ehac779. 125. (2023).","DOI":"10.1093\/eurheartj\/ehac779.125"},{"issue":"1","key":"50043_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong, Z. et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit. Med. 8 (1), 796. https:\/\/doi.org\/10.1038\/s41746-025-02172-2 (2025).","journal-title":"NPJ Digit. Med."},{"key":"50043_CR11","doi-asserted-by":"publisher","unstructured":"Xia, W. et al. Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chinese journal of cancer research\u2009=\u2009Chung-kuo yen cheng yen chiu. ;37(5):796\u2013820. (2025). https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.05.11","DOI":"10.21147\/j.issn.1000-9604.2025.05.11"},{"issue":"6","key":"50043_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang, P. et al. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance. Chin. J. cancer Res. = Chung-kuo yen cheng yen chiu. 37 (6), 1000\u20131019. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.06.11 (2025).","journal-title":"Chin. J. cancer Res. = Chung-kuo yen cheng yen chiu"},{"key":"50043_CR13","doi-asserted-by":"publisher","unstructured":"Zhang, X. et al. The combination of preoperative fibrinogen-to-albumin ratio and postoperative TNM stage (FAR-TNM) predicts the survival in gastric cancer patients after gastrectomy. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. ;28(8):714\u2013721. (2023). https:\/\/doi.org\/10.1080\/1354750x.2023.2281870","DOI":"10.1080\/1354750x.2023.2281870"},{"issue":"7","key":"50043_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1177\/10815589231179927","volume":"71","author":"LX Zhang","year":"2023","unstructured":"Zhang, L. X. et al. Prediction of overall survival after radical gastrectomy using nomograms created by tumor markers. J. Invest. medicine: official publication Am. Federation Clin. Res. 71 (7), 782\u2013790. https:\/\/doi.org\/10.1177\/10815589231179927 (2023).","journal-title":"J. Invest. medicine: official publication Am. Federation Clin. Res."},{"issue":"2","key":"50043_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1756283x16681709","volume":"10","author":"DD Suh","year":"2017","unstructured":"Suh, D. D., Oh, S. T., Yook, J. H., Kim, B. S. & Kim, B. S. Differences in the prognosis of early gastric cancer according to sex and age. Therapeutic Adv. Gastroenterol. 10 (2), 219\u2013229. https:\/\/doi.org\/10.1177\/1756283x16681709 (2017).","journal-title":"Therapeutic Adv. Gastroenterol."},{"issue":"13","key":"50043_CR16","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.1245\/s10434-021-10224-6","volume":"28","author":"S Choi","year":"2021","unstructured":"Choi, S. et al. Lymphovascular Invasion: Traditional but Vital and Sensible Prognostic Factor in Early Gastric Cancer. Ann. Surg. Oncol. 28 (13), 8928\u20138935. https:\/\/doi.org\/10.1245\/s10434-021-10224-6 (2021).","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"50043_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.suronc.2013.05.002","volume":"22","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. Surg. Oncol. 22 (3), 167\u2013171. https:\/\/doi.org\/10.1016\/j.suronc.2013.05.002 (2013).","journal-title":"Surg. Oncol."},{"key":"50043_CR18","doi-asserted-by":"publisher","unstructured":"Costantino, A. et al. Development of machine learning models to predict lymph node metastases in major salivary gland cancers. Ejso 49 (9). https:\/\/doi.org\/10.1016\/j.ejso.2023.06.017 (2023).","DOI":"10.1016\/j.ejso.2023.06.017"},{"key":"50043_CR19","doi-asserted-by":"publisher","unstructured":"Laros, S. S. A., Dickerscheid, D. B. M., Blazis, S. P. & van der Heide, J. A. Machine learning classification of mediastinal lymph node metastasis in NSCLC: a multicentre study in a Western European patient population. Ejnmmi Phys. 9 (1). https:\/\/doi.org\/10.1186\/s40658-022-00494-8 (2022).","DOI":"10.1186\/s40658-022-00494-8"},{"key":"50043_CR20","doi-asserted-by":"publisher","unstructured":"Qiu, B. X., Shen, Z. X., Yang, D. L. & Wang, Q. Applying machine learning techniques to predict the risk of lung metastases from rectal cancer: a real-world retrospective study. Front. Oncol. 13 https:\/\/doi.org\/10.3389\/fonc.2023.1183072 (2023).","DOI":"10.3389\/fonc.2023.1183072"},{"issue":"5","key":"50043_CR21","doi-asserted-by":"publisher","first-page":"e26580","DOI":"10.1016\/j.heliyon.2024.e26580","volume":"10","author":"CM Zhou","year":"2024","unstructured":"Zhou, C. M., Li, H., Xue, Q., Yang, J. J. & Zhu, Y. Artificial intelligence algorithms for predicting post-operative ileus after laparoscopic surgery. Heliyon 10 (5), e26580. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26580 (2024).","journal-title":"Heliyon"},{"issue":"4","key":"50043_CR22","first-page":"1683","volume":"44","author":"C-C Chang","year":"2024","unstructured":"Chang, C-C. et al. Machine-learning Algorithm-based Risk Prediction and Screening-detected Prostate Cancer in A Benign. Prostate Hyperplasia Cohort. 44 (4), 1683\u20131693 (2024).","journal-title":"Prostate Hyperplasia Cohort"},{"issue":"29","key":"50043_CR23","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.2217\/fon-2018-0299","volume":"14","author":"B Zhao","year":"2018","unstructured":"Zhao, B. et al. Assessment of the 8th edition of TNM staging system for gastric cancer: the results from the SEER and a single-institution database. Future Oncol. (London England). 14 (29), 3023\u20133035. https:\/\/doi.org\/10.2217\/fon-2018-0299 (2018).","journal-title":"Future Oncol. (London England)"},{"issue":"1","key":"50043_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7150\/jca.65339","volume":"13","author":"JR Yang","year":"2022","unstructured":"Yang, J. R. et al. The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib. J. Cancer. 13 (1), 15\u201320. https:\/\/doi.org\/10.7150\/jca.65339 (2022).","journal-title":"J. Cancer"},{"key":"50043_CR25","doi-asserted-by":"publisher","first-page":"1530522","DOI":"10.3389\/fonc.2025.1530522","volume":"15","author":"Y Jia","year":"2025","unstructured":"Jia, Y., Wang, Y., Li, H., Yang, Y. & Sun, M. Clinical value of CA125, AFP, and CEA for combined diagnosis and assessment of gastric cancer prognosis. Front. Oncol. 15, 1530522. https:\/\/doi.org\/10.3389\/fonc.2025.1530522 (2025).","journal-title":"Front. Oncol."},{"issue":"6","key":"50043_CR26","doi-asserted-by":"publisher","first-page":"e61609","DOI":"10.7759\/cureus.61609","volume":"16","author":"J Moriyama","year":"2024","unstructured":"Moriyama, J. et al. Prognostic Impact of Perioperative CA125 Status in Gastric Cancer Based on New Cutoff Values. Cureus 16 (6), e61609. https:\/\/doi.org\/10.7759\/cureus.61609 (2024).","journal-title":"Cureus"},{"issue":"24","key":"50043_CR27","doi-asserted-by":"publisher","first-page":"e3944","DOI":"10.1097\/md.0000000000003944","volume":"95","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. Impact of Age on the Prognosis of Operable Gastric Cancer Patients: An Analysis Based on SEER Database. Medicine 95 (24), e3944. https:\/\/doi.org\/10.1097\/md.0000000000003944 (2016).","journal-title":"Medicine"},{"issue":"2","key":"50043_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11605-018-04101-z","volume":"24","author":"JY Huang","year":"2020","unstructured":"Huang, J. Y. et al. The Prognosis Value of Lymphatic Vessel Invasion in pN0 Gastric Cancer Patients with Insufficient Examined Lymph Nodes. J. Gastrointest. surgery: official J. Soc. Surg. Aliment. Tract. 24 (2), 299\u2013306. https:\/\/doi.org\/10.1007\/s11605-018-04101-z (2020).","journal-title":"J. Gastrointest. surgery: official J. Soc. Surg. Aliment. Tract."},{"key":"50043_CR29","doi-asserted-by":"publisher","first-page":"3251051","DOI":"10.1155\/2022\/3251051","volume":"2022","author":"C Xiaobin","year":"2022","unstructured":"Xiaobin, C. et al. Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study. J. Immunol. Res. 2022, 3251051. https:\/\/doi.org\/10.1155\/2022\/3251051 (2022).","journal-title":"J. Immunol. Res."},{"key":"50043_CR30","doi-asserted-by":"publisher","first-page":"1183072","DOI":"10.3389\/fonc.2023.1183072","volume":"13","author":"B Qiu","year":"2023","unstructured":"Qiu, B., Shen, Z., Yang, D. & Wang, Q. Applying machine learning techniques to predict the risk of lung metastases from rectal cancer: a real-world retrospective study. Front. Oncol. 13, 1183072. https:\/\/doi.org\/10.3389\/fonc.2023.1183072 (2023).","journal-title":"Front. Oncol."},{"key":"50043_CR31","doi-asserted-by":"crossref","unstructured":"Sousa, N. et al. Homologous recombination deficiency as prognostic marker in metastatic gastric cancer (American Society of Clinical Oncology, 2019).","DOI":"10.1200\/JCO.2019.37.15_suppl.4040"},{"key":"50043_CR32","doi-asserted-by":"crossref","unstructured":"Qian, J. et al. OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer. ;64(1):37\u201348. (2015).","DOI":"10.1136\/gutjnl-2013-306584"},{"key":"50043_CR33","doi-asserted-by":"publisher","unstructured":"Lv, R. et al. Noninvasive detection of chromosomal instability in plasma circulating cell-free DNA for early pan-cancer diagnosis using low-pass whole-genome sequencing. J. Clin. Oncol. 39 (15). https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.e22509 (2021).","DOI":"10.1200\/JCO.2021.39.15_suppl.e22509"},{"issue":"11","key":"50043_CR34","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1158\/2159-8290.Cd-20-0036","volume":"10","author":"I Marigo","year":"2020","unstructured":"Marigo, I. et al. Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages. Cancer Discov. 10 (11), 1758\u20131773. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-0036 (2020).","journal-title":"Cancer Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50043-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50043-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50043-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:26:58Z","timestamp":1782080818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50043-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50043"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50043-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19209"}}